Works matching DE "PHASE II (Company)"

Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS).

Published in:

Annals of Hematology, 2012, v. 91, n. 1, p. 33, doi. 10.1007/s00277-011-1240-1

By:

• Cashen, Amanda;
• Juckett, Mark;
• Jumonville, Alcee;
• Litzow, Mark;
• Flynn, P.;
• Eckardt, John;
• LaPlant, Betsy;
• Laumann, Kristina;
• Erlichman, Charles;
• DiPersio, John

Publication type:

Article